Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY 4.0Frontiers in Veterinary Science

A homologous NADC34-like PRRSV-2 inactivated vaccine partially modulates pulmonary viral load and pathological lesions under controlled challenge conditions

  1. 1Viral Diseases Research Division, Animal and Plant Quarantine Agency, Gyeongsangbuk, Gimcheon, Gyeongsangbuk-do, Republic of Korea

Abstract

Background: Porcine reproductive and respiratory syndrome virus (PRRSV) continues to cause substantial economic losses in the global swine industry, largely due to its rapid genetic evolution and capacity for immune evasion. Lineage 1 NADC34-like variants have become increasingly prevalent in East Asia, raising concerns about the effectiveness of existing vaccines against these emerging strains.

Methods: Herein, the effects of an inactivated NADC34-like vaccine strain derived from a contemporary Korean isolate were evaluated under homologous experimental challenge conditions. The vaccine antigen was prepared at a high titer (108 TCID50/dose), formulated with different adjuvants, including Carbopol/squalene-based formulations, and administered to 3-week-old pigs, followed by an intranasal challenge with a homologous NADC34-like strain. Clinical parameters, blood and tissue viral loads, humoral and cellular immune responses, and pulmonary pathology were assessed.

Results: Vaccinated pigs, particularly those receiving Carbopol/squalene-based formulations, exhibited reduced body temperature and lung viral loads, and lower microscopic interstitial pneumonia scores compared with nonvaccinated controls. However, no consistent or statistically significant reduction in systemic viral kinetics was observed across the vaccinated groups.

Discussion: These findings indicate that homologous inactivated vaccination does not achieve complete systemic viral suppression but its efficacy is limited to clinical mitigation and the reduction of pulmonary pathological outcomes. The dissociation between systemic viral load and pulmonary pathology highlights the complexity of vaccine evaluation in PRRSV infection. Nevertheless, the alleviation of body temperature, body weight, and lung lesions is of great significance in terms of protective potential against PRRS, a wasting disease, conferred by the inactivated vaccine.

Related

  1. Photobiomodulation versus stabilization splint, both combined with self-management, for acute temporomandibular myalgia: 48-week outcomes of a partially randomized controlled study
    Nguyen Ngoc Hoa, Toan Do, Viet Hai Hoang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textGeneral biologyPhysiologyPLOSPMC
  2. Virtual Placebo: a scoping review of control conditions in randomized controlled trials of psychological immersive virtual reality interventions
    Madis Vasser, Mary-Ann Kubre, Kadi Tulver +1
    arXivPreprintCC BY-NC-ND 4.0Full textNeurosciencearXiv
  3. Preharvest temperature treatments influence physiological traits, secondary metabolites, and volatile compounds in holy basil under controlled environment conditions
    Patchareeya Boonkorkaew, Niafnan Hayi-asan, Akira Thongtip +7
    Scientific ReportsPeer-reviewedCC BYFull text1 citedPlant biologyDOAJ
  4. Subject-Specific Analysis of Self-Initiated Attention Shifts from EEG with Controlled Internal and External Attention Conditions
    Yuwen Zeng, Dengzhe Hou, Zhang Zhang +4
    arXivPreprintarXiv licenceFull textNeurosciencearXiv
  5. Heat-Inactivated Lactiplantibacillus plantarum (RSB11) as a Multifunctional Postbiotic: Anti-Inflammatory Effects Compared with Live RSB11 Across Multiple Human Cell Models
    Teodora Nicola, Tanmaya Madhvacharyula, Ajay Ashok +7
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
BibTeX
@article{you2026homologous,
  title = {{A homologous NADC34-like PRRSV-2 inactivated vaccine partially modulates pulmonary viral load and pathological lesions under controlled challenge conditions}},
  author = {Su-Hwa You and Hyun-Ji Lee and Seung-Min Song and Eun-Gyeong Shin and Jae-Myung Kim and Yeun-Kyung Shin and Seok-Jin Kang},
  journal = {Frontiers in Veterinary Science},
  year = {2026},
  month = oct,
  doi = {10.3389/fvets.2026.1932482},
  url = {https://doi.org/10.3389/fvets.2026.1932482},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A homologous NADC34-like PRRSV-2 inactivated vaccine partially modulates pulmonary viral load and pathological lesions under controlled challenge conditions
AU  - Su-Hwa You
AU  - Hyun-Ji Lee
AU  - Seung-Min Song
AU  - Eun-Gyeong Shin
AU  - Jae-Myung Kim
AU  - Yeun-Kyung Shin
AU  - Seok-Jin Kang
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Veterinary Science
DO  - 10.3389/fvets.2026.1932482
UR  - https://doi.org/10.3389/fvets.2026.1932482
AB  - Background: Porcine reproductive and respiratory syndrome virus (PRRSV) continues to cause substantial economic losses in the global swine industry, largely due to its rapid genetic evolution and capacity for immune evasion. Lineage 1 NADC34-like variants have become increasingly prevalent in East Asia, raising concerns about the effectiveness of existing vaccines against these emerging strains.  Methods: Herein, the effects of an inactivated NADC34-like vaccine strain derived from a contemporary Korean isolate were evaluated under homologous experimental challenge conditions. The vaccine antigen was prepared at a high titer (108 TCID50/dose), formulated with different adjuvants, including Carbopol/squalene-based formulations, and administered to 3-week-old pigs, followed by an intranasal challenge with a homologous NADC34-like strain. Clinical parameters, blood and tissue viral loads, humoral and cellular immune responses, and pulmonary pathology were assessed.  Results: Vaccinated pigs, particularly those receiving Carbopol/squalene-based formulations, exhibited reduced body temperature and lung viral loads, and lower microscopic interstitial pneumonia scores compared with nonvaccinated controls. However, no consistent or statistically significant reduction in systemic viral kinetics was observed across the vaccinated groups.  Discussion: These findings indicate that homologous inactivated vaccination does not achieve complete systemic viral suppression but its efficacy is limited to clinical mitigation and the reduction of pulmonary pathological outcomes. The dissociation between systemic viral load and pulmonary pathology highlights the complexity of vaccine evaluation in PRRSV infection. Nevertheless, the alleviation of body temperature, body weight, and lung lesions is of great significance in terms of protective potential against PRRS, a wasting disease, conferred by the inactivated vaccine.
SN  - 2297-1769
ER  -